COLL - Collegium Pharmaceutical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
463,933
463,933
276,868
310,016
296,701
Cost of Revenue
254,445
254,445
126,251
130,180
193,660
Gross Profit
209,488
209,488
150,617
179,836
103,041
Operating Expenses
Research Development
3,983
3,983
9,451
9,772
10,340
Selling General and Administrative
172,186
172,186
118,960
113,832
116,449
Total Operating Expenses
176,169
176,169
128,411
123,604
126,789
Operating Income or Loss
33,319
33,319
22,206
56,232
-23,748
Interest Expense
63,213
63,213
21,014
28,882
909
Total Other Income/Expenses Net
-
-
-4,578
-
-
Income Before Tax
-28,847
-28,847
-3,374
27,582
-22,722
Income Tax Expense
-3,845
-3,845
-74,891
830
-
Income from Continuing Operations
-25,002
-25,002
71,517
26,752
-22,722
Net Income
-25,002
-25,002
71,517
26,752
-22,722
Net Income available to common shareholders
-25,002
-25,002
71,517
26,752
-22,722
Basic EPS
-
-0.74
2.05
0.78
-0.68
Diluted EPS
-
-0.74
1.86
0.76
-0.68
Basic Average Shares
-
33,829
34,937
34,408
33,454
Diluted Average Shares
-
33,829
41,046
35,151
33,454
EBITDA
-
34,366
17,640
56,464
-21,813